Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
23 results
D1.466 - Atopic dermatitis increases the risk of chronic systemic diseases in children and adolescents: a nationwide nested case–control study
D1.472 - Features of the intestinal microbiota composition in infants with allergy: comparison of two diagnostic methods
D1.473 - Features of the intestinal microbiota composition in infants with IgE- and non-IgE-mediated allergy
D1.476 - Impact of neonatal vaccination on the incidence of atopic dermatitis in children by 36 months: a prospective cohort study
D1.480 - Polysomnographic phenotypes of sleep-disordered breathing in children with asthma: a systematic review
D1.467 - Economic Burden of Allergic Diseases in Children: Global Evidence and Implications for Kyrgyzstan
D1.468 - Association Between Autism Spectrum Disorder and Skin Barrier Integrity
D1.470 - Comparison of long-term (52 week therapy) maintenance vs. as-needed intranasal corticosteroid therapy in pediatric allergic rhinitis: assessment using exhaled breath condensate leukotriene E4
D1.471 - From Grandmother to Granddaughter: A Case Report of Hereditary Angioedema Diagnosed in the Third Generation
D1.475 - Significance of air-trapping and pulmonary hyperinflation in the severity of broncho-obstructive manifestations in children with cystic fibrosis
D1.478 - Hyper-IgE in allergic bronchopulmonary aspergillosis: diagnostic challenges
D1.479 - Lung function in children with cystic fibrosis associated with wheezing
D3.157 - Clinical characteristics and associated factors of persistent asthma in preschool children with wheezing in a tropical region
D3.158 - Dupilumab Response in a Patient with Severe Asthma Refractory to Anti-IL5 Therapy: A Case Report
D3.165 - Phase 1 study of CDX-622, a bispecific antibody targeting TSLP and mast cells via stem cell factor
D3.153 - Add-on Dupilumab therapy significantly reduces severe asthma exacerbations and emergency visits in patients with severe persistent asthma requiring oral corticosteroids for maintenance therapy: our experience in Réunion Island
D3.154 - Trends in Bronchial Asthma Incidence in Crimea: Analysis from 2017-2024 with Age-Specific Insights
D3.155 - Th2–Th17 immune shift following dupilumab therapy
D3.156 - Pulmonary embolism in a young asthma patient
D3.159 - Early Bronchodilator Response in Asthma: When Is Testing Really Necessary?
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download